270 related articles for article (PubMed ID: 22612670)
1. Familial pituitary adenomas - who should be tested for AIP mutations?
Korbonits M; Storr H; Kumar AV
Clin Endocrinol (Oxf); 2012 Sep; 77(3):351-6. PubMed ID: 22612670
[TBL] [Abstract][Full Text] [Related]
2. Aryl hydrocarbon receptor interacting protein (AIP) gene mutation analysis in children and adolescents with sporadic pituitary adenomas.
Georgitsi M; De Menis E; Cannavò S; Mäkinen MJ; Tuppurainen K; Pauletto P; Curtò L; Weil RJ; Paschke R; Zielinski G; Wasik A; Lubinski J; Vahteristo P; Karhu A; Aaltonen LA
Clin Endocrinol (Oxf); 2008 Oct; 69(4):621-7. PubMed ID: 18410548
[TBL] [Abstract][Full Text] [Related]
3. Aryl hydrocarbon receptor-interacting protein gene mutations in familial isolated pituitary adenomas: analysis in 73 families.
Daly AF; Vanbellinghen JF; Khoo SK; Jaffrain-Rea ML; Naves LA; Guitelman MA; Murat A; Emy P; Gimenez-Roqueplo AP; Tamburrano G; Raverot G; Barlier A; De Herder W; Penfornis A; Ciccarelli E; Estour B; Lecomte P; Gatta B; Chabre O; Sabaté MI; Bertagna X; Garcia Basavilbaso N; Stalldecker G; Colao A; Ferolla P; Wémeau JL; Caron P; Sadoul JL; Oneto A; Archambeaud F; Calender A; Sinilnikova O; Montañana CF; Cavagnini F; Hana V; Solano A; Delettieres D; Luccio-Camelo DC; Basso A; Rohmer V; Brue T; Bours V; Teh BT; Beckers A
J Clin Endocrinol Metab; 2007 May; 92(5):1891-6. PubMed ID: 17244780
[TBL] [Abstract][Full Text] [Related]
4. [AIP mutations in familial and sporadic pituitary adenomas: local experience and review of the literature].
Fajardo-Montañana C; Daly AF; Riesgo-Suárez P; Gómez-Vela J; Tichomirowa MA; Camara-Gómez R; Beckers A
Endocrinol Nutr; 2009; 56(7):369-77. PubMed ID: 19883897
[TBL] [Abstract][Full Text] [Related]
5. Molecular genetics of the aip gene in familial pituitary tumorigenesis.
Tahir A; Chahal HS; Korbonits M
Prog Brain Res; 2010; 182():229-53. PubMed ID: 20541668
[TBL] [Abstract][Full Text] [Related]
6. [Aryl hydrocarbon receptor interacting protein gene and familial isolated pituitary adenomas].
Cai F; Zhang YD; Dai CX; Liu XH; Yang YK; Yao Y; Wang RZ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2012 Dec; 34(6):640-4. PubMed ID: 23286415
[TBL] [Abstract][Full Text] [Related]
7. Pituitary adenoma predisposition caused by germline mutations in the AIP gene.
Vierimaa O; Georgitsi M; Lehtonen R; Vahteristo P; Kokko A; Raitila A; Tuppurainen K; Ebeling TM; Salmela PI; Paschke R; Gündogdu S; De Menis E; Mäkinen MJ; Launonen V; Karhu A; Aaltonen LA
Science; 2006 May; 312(5777):1228-30. PubMed ID: 16728643
[TBL] [Abstract][Full Text] [Related]
8. Mutations of the gene for the aryl hydrocarbon receptor-interacting protein in pituitary adenomas.
Cazabat L; Guillaud-Bataille M; Bertherat J; Raffin-Sanson ML
Horm Res; 2009; 71(3):132-41. PubMed ID: 19188737
[TBL] [Abstract][Full Text] [Related]
9. Germline AIP mutations in apparently sporadic pituitary adenomas: prevalence in a prospective single-center cohort of 443 patients.
Cazabat L; Bouligand J; Salenave S; Bernier M; Gaillard S; Parker F; Young J; Guiochon-Mantel A; Chanson P
J Clin Endocrinol Metab; 2012 Apr; 97(4):E663-70. PubMed ID: 22319033
[TBL] [Abstract][Full Text] [Related]
10. AIP gene and familial isolated pituitary adenomas.
Ozfirat Z; Korbonits M
Mol Cell Endocrinol; 2010 Sep; 326(1-2):71-9. PubMed ID: 20457215
[TBL] [Abstract][Full Text] [Related]
11. Landscape of Familial Isolated and Young-Onset Pituitary Adenomas: Prospective Diagnosis in AIP Mutation Carriers.
Hernández-Ramírez LC; Gabrovska P; Dénes J; Stals K; Trivellin G; Tilley D; Ferrau F; Evanson J; Ellard S; Grossman AB; Roncaroli F; Gadelha MR; Korbonits M;
J Clin Endocrinol Metab; 2015 Sep; 100(9):E1242-54. PubMed ID: 26186299
[TBL] [Abstract][Full Text] [Related]
12. Aggressive pituitary adenomas occurring in young patients in a large Polynesian kindred with a germline R271W mutation in the AIP gene.
Jennings JE; Georgitsi M; Holdaway I; Daly AF; Tichomirowa M; Beckers A; Aaltonen LA; Karhu A; Cameron FJ
Eur J Endocrinol; 2009 Nov; 161(5):799-804. PubMed ID: 19684062
[TBL] [Abstract][Full Text] [Related]
13. Familial isolated pituitary adenomas (FIPA) and the pituitary adenoma predisposition due to mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene.
Beckers A; Aaltonen LA; Daly AF; Karhu A
Endocr Rev; 2013 Apr; 34(2):239-77. PubMed ID: 23371967
[TBL] [Abstract][Full Text] [Related]
14. Molecular diagnosis of pituitary adenoma predisposition caused by aryl hydrocarbon receptor-interacting protein gene mutations.
Georgitsi M; Raitila A; Karhu A; Tuppurainen K; Mäkinen MJ; Vierimaa O; Paschke R; Saeger W; van der Luijt RB; Sane T; Robledo M; De Menis E; Weil RJ; Wasik A; Zielinski G; Lucewicz O; Lubinski J; Launonen V; Vahteristo P; Aaltonen LA
Proc Natl Acad Sci U S A; 2007 Mar; 104(10):4101-5. PubMed ID: 17360484
[TBL] [Abstract][Full Text] [Related]
15. The role of the aryl hydrocarbon receptor-interacting protein gene in familial and sporadic pituitary adenomas.
Leontiou CA; Gueorguiev M; van der Spuy J; Quinton R; Lolli F; Hassan S; Chahal HS; Igreja SC; Jordan S; Rowe J; Stolbrink M; Christian HC; Wray J; Bishop-Bailey D; Berney DM; Wass JA; Popovic V; Ribeiro-Oliveira A; Gadelha MR; Monson JP; Akker SA; Davis JR; Clayton RN; Yoshimoto K; Iwata T; Matsuno A; Eguchi K; Musat M; Flanagan D; Peters G; Bolger GB; Chapple JP; Frohman LA; Grossman AB; Korbonits M
J Clin Endocrinol Metab; 2008 Jun; 93(6):2390-401. PubMed ID: 18381572
[TBL] [Abstract][Full Text] [Related]
16. Hyperplasia-adenoma sequence in pituitary tumorigenesis related to aryl hydrocarbon receptor interacting protein gene mutation.
Villa C; Lagonigro MS; Magri F; Koziak M; Jaffrain-Rea ML; Brauner R; Bouligand J; Junier MP; Di Rocco F; Sainte-Rose C; Beckers A; Roux FX; Daly AF; Chiovato L
Endocr Relat Cancer; 2011 Jun; 18(3):347-56. PubMed ID: 21450940
[TBL] [Abstract][Full Text] [Related]
17. Update on familial pituitary tumors: from multiple endocrine neoplasia type 1 to familial isolated pituitary adenoma.
Daly AF; Tichomirowa MA; Beckers A
Horm Res; 2009 Jan; 71 Suppl 1():105-11. PubMed ID: 19153518
[TBL] [Abstract][Full Text] [Related]
18. Cyclin-dependent kinase inhibitor 1B (CDKN1B) gene variants in AIP mutation-negative familial isolated pituitary adenoma kindreds.
Tichomirowa MA; Lee M; Barlier A; Daly AF; Marinoni I; Jaffrain-Rea ML; Naves LA; Rodien P; Rohmer V; Faucz FR; Caron P; Estour B; Lecomte P; Borson-Chazot F; Penfornis A; Yaneva M; Guitelman M; Castermans E; Verhaege C; Wémeau JL; Tabarin A; Fajardo Montañana C; Delemer B; Kerlan V; Sadoul JL; Cortet Rudelli C; Archambeaud F; Zacharieva S; Theodoropoulou M; Brue T; Enjalbert A; Bours V; Pellegata NS; Beckers A
Endocr Relat Cancer; 2012 Jun; 19(3):233-41. PubMed ID: 22291433
[TBL] [Abstract][Full Text] [Related]
19. Low rate of germline AIP mutations in patients with apparently sporadic pituitary adenomas before the age of 40: a single-centre adult cohort.
Preda V; Korbonits M; Cudlip S; Karavitaki N; Grossman AB
Eur J Endocrinol; 2014 Nov; 171(5):659-66. PubMed ID: 25184284
[TBL] [Abstract][Full Text] [Related]
20. Aryl hydrocarbon receptor interacting protein gene (AIP) mutations are rare in patients with hormone secreting or non-secreting pituitary adenomas.
Buchbinder S; Bierhaus A; Zorn M; Nawroth PP; Humpert P; Schilling T
Exp Clin Endocrinol Diabetes; 2008 Nov; 116(10):625-8. PubMed ID: 18484068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
